Table 2.
Glucose Characteristics of PEAR‐2 and PEAR Participants
| Glucose Characteristics | PEAR‐2 (Chlorthalidone) | PEAR (Hydrochlorothiazide) | ||
|---|---|---|---|---|
| Blacks (n=135) | Whites (n=175) | Blacks (n=139) | Whites (n=222) | |
| Baseline glucose, mg/dL | 94.46±11.37 | 94.18±9.39 | 90.65±12.78 | 92.85±12.28 |
| Glucose post‐treatment, mg/dL | 99.77±6.23 | 99.10±16.23 | 93.1±14.84 | 93.82±11.93 |
| Glucose change, mg/dL | 4.30±9.83 | 4.39±7.51 | 2.38±10.82 | 0.97±10.13a |
Values are presented as mean±SD unless otherwise noted. PEAR indicates Pharmacogenomic Evaluation of Antihypertensive Response.
a
Indicates P≤0.05 for chlorthalidone (PEAR‐2) vs Hydrochlorothiazide (PEAR) within race.